Smith+Nephew received FDA 510(k) clearance for its LANDMARK Total Knee System and completed the first surgical case using the knee replacement technology.
The LANDMARK Knee is designed for total knee arthroplasty and can be used with Smith+Nephew’s CORI KNEE Handheld Robotics Arthroplasty platform. The system features a fully 3D-printed femoral component and was designed to replicate healthy knee anatomy and natural motion, supporting a more personalized approach to knee replacement. The CORI KNEE platform’s compact, mobile footprint is built to work across both hospital and ASC settings, according to a Sept. 22 news release.
Steven MacDonald, MD, professor of orthopedic surgery at Western University and London Health Sciences Centre in Canada, completed the first LANDMARK Knee surgical case. Dr. MacDonald helped design and develop the implant system. Steven Haas, MD, chief of the knee service at Hospital for Special Surgery in New York City, also helped develop the system.
Smith+Nephew plans a phased commercial launch, with broader availability across markets expected throughout 2027.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
